Phase I and II Study of Induction Chemotherapy With Methotrexate, Rituximab, and Temozolomide, Followed By Whole-Brain Radiotherapy and Postirradiation Temozolomide for Primary CNS Lymphoma: NRG Oncology RTOG 0227

Jon Glass; Minhee Won; Christopher J. Schultz; Daniel Brat; Nancy L. Bartlett; John H. Suh; Maria Werner-Wasik; Barbara Jean Fisher; Marcia K. Liepman; Mark Augspurger; Felix Bokstein; Joseph A. Bovi; Matthew C. Solhjem; Minesh P. Mehta

doi:10.1200/JCO.2015.64.8634

Phase I and II Study of Induction Chemotherapy With Methotrexate, Rituximab, and Temozolomide, Followed By Whole-Brain Radiotherapy and Postirradiation Temozolomide for Primary CNS Lymphoma: NRG Oncology RTOG 0227

Jon Glass
, Minhee Won
, Christopher J. Schultz
, Daniel Brat
, Nancy L. Bartlett
, John H. Suh
, Maria Werner-Wasik
, Barbara Jean Fisher
, Marcia K. Liepman
, Mark Augspurger
, Felix Bokstein
, Joseph A. Bovi
, Matthew C. Solhjem
, Minesh P. Mehta

Miami Cancer Institute

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Journal of Clinical Oncology
Volume	34
DOIs	https://doi.org/10.1200/JCO.2015.64.8634
State	Published - May 10 2016

Disciplines

Medicine and Health Sciences
Surgery
Immunology and Infectious Disease
Other Medical Specialties

Access to Document

10.1200/JCO.2015.64.8634License: Unspecified

Cite this

Glass, J., Won, M., Schultz, C. J., Brat, D., Bartlett, N. L., Suh, J. H., Werner-Wasik, M., Fisher, B. J., Liepman, M. K., Augspurger, M., Bokstein, F., Bovi, J. A., Solhjem, M. C., & Mehta, M. P. (2016). Phase I and II Study of Induction Chemotherapy With Methotrexate, Rituximab, and Temozolomide, Followed By Whole-Brain Radiotherapy and Postirradiation Temozolomide for Primary CNS Lymphoma: NRG Oncology RTOG 0227. Journal of Clinical Oncology, 34. https://doi.org/10.1200/JCO.2015.64.8634

Phase I and II Study of Induction Chemotherapy With Methotrexate, Rituximab, and Temozolomide, Followed By Whole-Brain Radiotherapy and Postirradiation Temozolomide for Primary CNS Lymphoma: NRG Oncology RTOG 0227. / Glass, Jon; Won, Minhee; Schultz, Christopher J. et al.
In: Journal of Clinical Oncology, Vol. 34, 10.05.2016.

Research output: Contribution to journal › Article › peer-review

Glass, J, Won, M, Schultz, CJ, Brat, D, Bartlett, NL, Suh, JH, Werner-Wasik, M, Fisher, BJ, Liepman, MK, Augspurger, M, Bokstein, F, Bovi, JA, Solhjem, MC & Mehta, MP 2016, 'Phase I and II Study of Induction Chemotherapy With Methotrexate, Rituximab, and Temozolomide, Followed By Whole-Brain Radiotherapy and Postirradiation Temozolomide for Primary CNS Lymphoma: NRG Oncology RTOG 0227', Journal of Clinical Oncology, vol. 34. https://doi.org/10.1200/JCO.2015.64.8634

@article{18ab591aac3042f7a6b648f9867c4f7d,

title = "Phase I and II Study of Induction Chemotherapy With Methotrexate, Rituximab, and Temozolomide, Followed By Whole-Brain Radiotherapy and Postirradiation Temozolomide for Primary CNS Lymphoma: NRG Oncology RTOG 0227",

author = "Jon Glass and Minhee Won and Schultz, \{Christopher J.\} and Daniel Brat and Bartlett, \{Nancy L.\} and Suh, \{John H.\} and Maria Werner-Wasik and Fisher, \{Barbara Jean\} and Liepman, \{Marcia K.\} and Mark Augspurger and Felix Bokstein and Bovi, \{Joseph A.\} and Solhjem, \{Matthew C.\} and Mehta, \{Minesh P.\}",

note = "In order to access this website, please configure your browser to support cookies.",

year = "2016",

month = may,

day = "10",

doi = "10.1200/JCO.2015.64.8634",

language = "American English",

volume = "34",

journal = "Journal of Clinical Oncology",

}

TY - JOUR

T1 - Phase I and II Study of Induction Chemotherapy With Methotrexate, Rituximab, and Temozolomide, Followed By Whole-Brain Radiotherapy and Postirradiation Temozolomide for Primary CNS Lymphoma: NRG Oncology RTOG 0227

AU - Glass, Jon

AU - Won, Minhee

AU - Schultz, Christopher J.

AU - Brat, Daniel

AU - Bartlett, Nancy L.

AU - Suh, John H.

AU - Werner-Wasik, Maria

AU - Fisher, Barbara Jean

AU - Liepman, Marcia K.

AU - Augspurger, Mark

AU - Bokstein, Felix

AU - Bovi, Joseph A.

AU - Solhjem, Matthew C.

AU - Mehta, Minesh P.

N1 - In order to access this website, please configure your browser to support cookies.

PY - 2016/5/10

Y1 - 2016/5/10

UR - http://ascopubs.org/doi/full/10.1200/JCO.2015.64.8634

U2 - 10.1200/JCO.2015.64.8634

DO - 10.1200/JCO.2015.64.8634

M3 - Article

VL - 34

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

ER -

Phase I and II Study of Induction Chemotherapy With Methotrexate, Rituximab, and Temozolomide, Followed By Whole-Brain Radiotherapy and Postirradiation Temozolomide for Primary CNS Lymphoma: NRG Oncology RTOG 0227

Disciplines

Access to Document

Other files and links

Cite this